Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALPA.NS Stock Summary
Top 10 Correlated ETFs
ALPA.NS
In the News
ALPA.NS Financial details
Company Rating
Buy
Market Cap
2.06B
Income
185.94M
Revenue
1.14B
Book val./share
68.08
Cash/share
51.57
Dividend
-
Dividend %
-
Employees
318
Optionable
No
Shortable
Yes
Earnings
12 Feb 2024
P/E
10.86
Forward P/E
-
PEG
3.6
P/S
1.77
P/B
1.41
P/C
1.86
P/FCF
-
Quick Ratio
3.92
Current Ratio
4.38
Debt / Equity
0.01
LT Debt / Equity
-
-
-
EPS (TTM)
8.72
EPS next Y
-
EPS next Q
-
EPS this Y
-10.75%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
73.53%
Revenue last 5Y
3.88%
Revenue Q/Q
27.39%
EPS Q/Q
90.97%
-
-
-
-
SMA20
32.59%
SMA50
26.65%
SMA100
39.75%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
27%
ROC
0.15%
Gross Margin
33%
Oper. Margin
19%
Profit Margin
16%
Payout
-
Shs Outstand
21.04M
Shs Float
7.81M
-
-
-
-
Target Price
-
52W Range
50.3-106.6
52W High
-9.48%
52W Low
+91.9%
RSI
65.97
Rel Volume
0.57
Avg Volume
238.95K
Volume
136.24K
Perf Week
1.16%
Perf Month
27.17%
Perf Quarter
48.99%
Perf Half Y
53.15%
-
-
-
-
Beta
0.675
-
-
Volatility
1.85%, 10.87%
Prev Close
-1.99%
Price
95.95
Change
-2.79%
ALPA.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 36.32 | 40.34 | 45.82 | 52.52 | 43.93 | |
Net income per share | 0.38 | 0.88 | 3.44 | 6.7 | 6 | |
Operating cash flow per share | -0.76 | 8.45 | -0.8 | 1.03 | -2.3 | |
Free cash flow per share | -1.16 | 7.24 | -2.33 | -0.01 | -2.84 | |
Cash per share | 14.31 | 21.04 | 20.19 | 33.4 | 39.92 | |
Book value per share | 46.71 | 47.7 | 51.16 | 57.86 | 63.96 | |
Tangible book value per share | 45.75 | 47.7 | 51.13 | 57.76 | 63.92 | |
Share holders equity per share | 46.71 | 47.7 | 51.16 | 57.86 | 63.96 | |
Interest debt per share | 1.02 | 0.24 | 0.1 | 2.83 | 1.2 | |
Market cap | 567.04M | 291.41M | 757.48M | 1.47B | 1.13B | |
Enterprise value | 582.22M | 245.78M | 741.38M | 1.51B | 1.07B | |
P/E ratio | 71.43 | 15.72 | 10.45 | 10.41 | 8.96 | |
Price to sales ratio | 0.74 | 0.34 | 0.79 | 1.33 | 1.22 | |
POCF ratio | -35.66 | 1.64 | -44.75 | 67.58 | -23.36 | |
PFCF ratio | -23.24 | 1.91 | -15.43 | -7.33K | -18.95 | |
P/B Ratio | 0.58 | 0.29 | 0.7 | 1.2 | 0.84 | |
PTB ratio | 0.58 | 0.29 | 0.7 | 1.2 | 0.84 | |
EV to sales | 0.76 | 0.29 | 0.77 | 1.37 | 1.15 | |
Enterprise value over EBITDA | 8.25 | 2.39 | 6.59 | 11.6 | 6.1 | |
EV to operating cash flow | -36.62 | 1.38 | -43.8 | 69.55 | -22.02 | |
EV to free cash flow | -23.86 | 1.61 | -15.1 | -7.55K | -17.86 | |
Earnings yield | 0.01 | 0.06 | 0.1 | 0.1 | 0.11 | |
Free cash flow yield | -0.04 | 0.52 | -0.06 | 0 | -0.05 | |
Debt to equity | 0.02 | 0 | 0 | 0.05 | 0.02 | |
Debt to assets | 0.01 | 0 | 0 | 0.04 | 0.01 | |
Net debt to EBITDA | 0.22 | -0.44 | -0.14 | 0.33 | -0.37 | |
Current ratio | 4.22 | 4.6 | 3.73 | 4.43 | 5.06 | |
Interest coverage | 0.5 | 49.55 | 283.7 | 84.25 | 30.27 | |
Income quality | -0.63 | 6.12 | -0.16 | 0.11 | -0.31 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.21 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.53 | -0.14 | 1.9 | -1.01 | 0.23 | |
Capex to revenue | -0.01 | -0.03 | -0.03 | -0.02 | -0.01 | |
Capex to depreciation | -0.27 | -0.8 | -2.62 | -1.32 | -0.85 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 19.91 | 30.75 | 62.96 | 93.37 | 92.95 | |
ROIC | 0 | 0.03 | 0.05 | 0.05 | 0.04 | |
Return on tangible assets | 0.01 | 0.02 | 0.05 | 0.09 | 0.08 | |
Graham Net | 23.31 | 14.05 | 26.85 | 37.52 | 44.16 | |
Working capital | 717.77M | 746.96M | 885.88M | 1.08B | 1.22B | |
Tangible asset value | 962.55M | 754.2M | 1.08B | 1.22B | 1.34B | |
Net current asset value | 713.66M | 744.94M | 883.63M | 1.05B | 1.19B | |
Invested capital | 0.02 | 0 | 0 | 0.05 | 0.02 | |
Average receivables | 230.22M | 230.84M | 256.32M | 485.98M | 466.14M | |
Average payables | 132.21M | 134.42M | 192.15M | 198.27M | 149.91M | |
Average inventory | 138.79M | 132.95M | 145.55M | 160.12M | 140.52M | |
Days sales outstanding | 220.5 | 0 | 194.07 | 151.7 | 186.75 | |
Days payables outstanding | 90.66 | 90.46 | 139.4 | 71.59 | 87 | |
Days of inventory on hand | 96.52 | 82.88 | 93.34 | 74.18 | 73.03 | |
Receivables turnover | 1.66 | 0 | 1.88 | 2.41 | 1.95 | |
Payables turnover | 4.03 | 4.04 | 2.62 | 5.1 | 4.2 | |
Inventory turnover | 3.78 | 4.4 | 3.91 | 4.92 | 5 | |
ROE | 0.01 | 0.02 | 0.07 | 0.12 | 0.09 | |
Capex per share | -0.4 | -1.21 | -1.53 | -1.04 | -0.54 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.71 | 12.97 | 12.88 | 12.07 | 15.39 | |
Net income per share | 0.1 | 2.43 | 2.05 | 1.44 | 2.75 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 36.4 | 0 | 37.1 | 0 | 51.57 | |
Book value per share | 56.3 | 0 | 59.44 | 0 | 68.08 | |
Tangible book value per share | 56.25 | 0 | 59.4 | 0 | 68.08 | |
Share holders equity per share | 56.3 | 0 | 59.44 | 0 | 68.08 | |
Interest debt per share | 6.93 | 0.03 | 1.03 | 0.01 | 0.75 | |
Market cap | 1.21B | 1.33B | 1.22B | 1.49B | 1.54B | |
Enterprise value | 1.32B | 1.33B | 1.15B | 1.49B | 1.53B | |
P/E ratio | 150.12 | 6.48 | 6.55 | 12.32 | 6.66 | |
Price to sales ratio | 8.96 | 4.86 | 4.18 | 5.88 | 4.76 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 1.07 | 0 | 0.91 | 0 | 1.08 | |
PTB ratio | 1.07 | 0 | 0.91 | 0 | 1.08 | |
EV to sales | 9.71 | 4.86 | 3.95 | 5.88 | 4.73 | |
Enterprise value over EBITDA | 205.76 | 25.07 | 13.53 | 45.32 | 24.32 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0.04 | 0.04 | 0.02 | 0.04 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.12 | 0 | 0.02 | 0 | 0.01 | |
Debt to assets | 0.09 | 0 | 0.01 | 0 | 0.01 | |
Net debt to EBITDA | 16.05 | 0 | -0.76 | 0 | -0.14 | |
Current ratio | 4.62 | 0 | 5.06 | 0 | 4.38 | |
Interest coverage | 3.49 | 70.65 | 225.22 | 177.74 | 245.28 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 11.25 | 0 | 52.42 | 0 | 64.9 | |
ROIC | 0 | 0 | 0.03 | 0 | 0.04 | |
Return on tangible assets | 0 | 0 | 0.03 | 0 | 0.03 | |
Graham Net | 34.47 | 0 | 41.04 | 0 | 50.15 | |
Working capital | 1.1B | 702M | 1.22B | 821.82M | 1.29B | |
Tangible asset value | 1.14B | 0 | 1.34B | 0 | 1.43B | |
Net current asset value | 975.11M | 702M | 1.19B | 821.82M | 1.27B | |
Invested capital | 0.12 | 0 | 0.02 | 0 | 0.01 | |
Average receivables | 206.26M | 206.26M | 236.48M | 236.48M | 208.71M | |
Average payables | 84.65M | 84.65M | 75.29M | 75.29M | 124.23M | |
Average inventory | 79.42M | 79.42M | 63.21M | 63.21M | 63.02M | |
Days sales outstanding | 274.1 | 0 | 145.98 | 0 | 115.97 | |
Days payables outstanding | 105 | 0 | 98.2 | 0 | 100.19 | |
Days of inventory on hand | 98.51 | 0 | 82.44 | 0 | 50.82 | |
Receivables turnover | 0.33 | 0 | 0.62 | 0 | 0.78 | |
Payables turnover | 0.86 | 0 | 0.92 | 0 | 0.9 | |
Inventory turnover | 0.91 | 0 | 1.09 | 0 | 1.77 | |
ROE | 0 | 0 | 0.03 | 0 | 0.04 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ALPA.NS Frequently Asked Questions
What is Alpa Laboratories Limited stock symbol ?
Alpa Laboratories Limited is a IN stock and trading under the symbol ALPA.NS
What is Alpa Laboratories Limited stock quote today ?
Alpa Laboratories Limited stock price is $95.95 today.
Is Alpa Laboratories Limited stock public?
Yes, Alpa Laboratories Limited is a publicly traded company.